JPWO2023209326A5 - - Google Patents

Info

Publication number
JPWO2023209326A5
JPWO2023209326A5 JP2024563502A JP2024563502A JPWO2023209326A5 JP WO2023209326 A5 JPWO2023209326 A5 JP WO2023209326A5 JP 2024563502 A JP2024563502 A JP 2024563502A JP 2024563502 A JP2024563502 A JP 2024563502A JP WO2023209326 A5 JPWO2023209326 A5 JP WO2023209326A5
Authority
JP
Japan
Prior art keywords
modified bont
muscle
administered
capitis
bont
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024563502A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025514275A (ja
JP2025514275A5 (https=
Publication date
Priority claimed from GBGB2206353.1A external-priority patent/GB202206353D0/en
Application filed filed Critical
Publication of JP2025514275A publication Critical patent/JP2025514275A/ja
Publication of JPWO2023209326A5 publication Critical patent/JPWO2023209326A5/ja
Publication of JP2025514275A5 publication Critical patent/JP2025514275A5/ja
Pending legal-status Critical Current

Links

JP2024563502A 2022-04-29 2023-03-23 頸部ジストニアの治療 Pending JP2025514275A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2206353.1A GB202206353D0 (en) 2022-04-29 2022-04-29 Treatment of cervical dystonia
GB2206353.1 2022-04-29
PCT/GB2023/050742 WO2023209326A1 (en) 2022-04-29 2023-03-23 Treatment of cervical dystonia

Publications (3)

Publication Number Publication Date
JP2025514275A JP2025514275A (ja) 2025-05-02
JPWO2023209326A5 true JPWO2023209326A5 (https=) 2026-03-31
JP2025514275A5 JP2025514275A5 (https=) 2026-03-31

Family

ID=81943814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024563502A Pending JP2025514275A (ja) 2022-04-29 2023-03-23 頸部ジストニアの治療

Country Status (9)

Country Link
US (1) US20250302928A1 (https=)
EP (1) EP4514378A1 (https=)
JP (1) JP2025514275A (https=)
KR (1) KR20250004869A (https=)
CN (1) CN119110728A (https=)
AU (1) AU2023262641A1 (https=)
CA (1) CA3245899A1 (https=)
GB (1) GB202206353D0 (https=)
WO (1) WO2023209326A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025231403A1 (en) * 2024-05-03 2025-11-06 Revivity Pharma Corporation Methods of administering and manufacturing toxic compounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
DE102004043009A1 (de) 2004-09-06 2006-03-23 Toxogen Gmbh Transportprotein zum Einbringen chemischer Verbindungen in Nervenzellen
DE102005019302A1 (de) 2005-04-26 2006-11-16 Toxogen Gmbh Carrier zum Targeting von Nervenzellen
ES2369558T3 (es) 2005-09-19 2011-12-01 Allergan, Inc. Toxinas clostridiales y toxinas clostridiales activables.
CA2758274C (en) 2009-04-14 2018-04-10 Mcw Research Foundation, Inc. Engineered botulinum neurotoxin
US8853360B2 (en) 2010-06-23 2014-10-07 Wisconsin Alumni Research Foundation Engineered botulinum neurotoxin C1 with selective substrate specificity
EP3162894B1 (en) 2011-05-19 2024-01-10 Ipsen Bioinnovation Limited Methods for the manufacture of proteolytically processed polypeptides
SG10201606666XA (en) 2012-05-30 2016-09-29 Harvard College Engineered Botulinum Neurotoxin
WO2014079495A1 (en) 2012-11-21 2014-05-30 Syntaxin Limited Methods for the manufacture of proteolytically processed polypeptides
GB201312317D0 (en) 2013-07-09 2013-08-21 Syntaxin Ltd Cationic neurotoxins
PT3274364T (pt) 2015-03-26 2021-11-05 Harvard College Neurotoxina botulínica manipulada
GB201607901D0 (en) 2016-05-05 2016-06-22 Ipsen Biopharm Ltd Chimeric neurotoxins
EP3481852B1 (en) 2016-07-08 2022-12-07 Children's Medical Center Corporation A novel botulinum neurotoxin and its derivatives
TWI810228B (zh) * 2017-12-20 2023-08-01 英商艾普森生物製藥有限公司 自主神經系統障礙之治療
JP2024534384A (ja) * 2021-09-16 2024-09-20 イプセン バイオファーム リミテッド 頸部ジストニアを治療する用途の修飾ＢｏＮＴ／Ａ

Similar Documents

Publication Publication Date Title
JP2019523015A5 (https=)
Hobson et al. Botulinum toxin injection for cervicogenic headache
JP4249802B2 (ja) 神経筋疾患および症状を処置するためのボツリヌス毒素組み合わせ
JP2019216735A5 (https=)
US7223577B2 (en) Post-translational modifications and Clostridial neurotoxins
JP2015522576A5 (https=)
Neumann Swallowing therapy with neurologic patients: results of direct and indirect therapy methods in 66 patients suffering from neurological disorders
JP2019528042A5 (https=)
JP2012530504A5 (https=)
JPH09507234A (ja) 種々の疾病およびそれに伴う疼痛を処置するためのボツリヌス毒素
JP2005281317A (ja) ジストニーを処置するためのａ型ボツリヌス毒素に続くｂ型ボツリヌス毒素の使用
SI2206728T1 (en) Methods for the treatment of bone cancer pain by administration of an antagonist nerve growth factor
JP2004536778A (ja) 変化した生物学的持続性を有する改変クロストリジウム神経毒
EP0679090A1 (en) Method for treating myofascial pain syndrome
RU2001134170A (ru) Антигенные пептиды NEISSERIA
Hamby et al. Spasmodic torticollis: results after cervical rhizotomy in 50 cases
JP2006506942A5 (https=)
JPWO2023209326A5 (https=)
CA2342770A1 (en) Ly6h gene
JPWO2023041934A5 (https=)
WO2024051845A1 (zh) 用于防治后遗症期面神经麻痹的药物组合物及其应用
CN103501794A (zh) 脑靶向性功能性核酸及其利用
RU2024110144A (ru) Лечение цервикальной дистонии
RU2024129876A (ru) Лечение шейной дистонии
RU2020117362A (ru) Способы лечения тендинопатии с помощью антагонистов интерлейкина-17 (il-17)